Latest News about GKOS
Recent news which mentions GKOS
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
From Benzinga
Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants
December 22, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
December 19, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
From Benzinga
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
November 04, 2022
From Benzinga
Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock
October 04, 2022
Tickers
GKOS
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
From Benzinga
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday
September 08, 2022
From Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
From Benzinga
Dow Jumps 450 Points; UiPath Shares Slide
September 07, 2022
From Benzinga
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
September 07, 2022
From Benzinga
Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday
September 07, 2022
From Benzinga
Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate
September 07, 2022
Tickers
GKOS
From Benzinga
Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment
August 24, 2022
Tickers
GKOS
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 03, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free